IP Library Granted Patent US 9,909,149
Granted Patent B2
US 9,909,149 · App. 15/485,735 · Granted Mar 6, 2018

DHAD variants for butanol production

Inventors: Lori Ann Maggio-Hall (Wilmington, DE); Brian James Paul (Wilmington, DE); Steven Cary Rothman (Wilmington, DE); Rick W. Ye (Hockessin, DE)
Assignee: Butamax Advanced Biofuels LLC
C12P7/16C12N9/88C12N15/00C12P7/40C12Y402/01009
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,909,149
App. No.
15/485,735
Granted
Mar 6, 2018
Kind
B2
Abstract

Dihydroxy-acid dehydratase (DHAD) variants that display increased DHAD activity are disclosed. Such enzymes can result in increased production of compounds from DHAD requiring biosynthetic pathways. Also disclosed are isolated nucleic acids encoding the DHAD variants, recombinant host cells comprising the isolated nucleic acid molecules, and methods of producing butanol.

Claims (23)

1. A method for producing isobutanol comprising:

(a) providing a recombinant host cell comprising a polypeptide or fragment thereof having dihydroxy-acid dehydratase (DHAD) activity, wherein the polypeptide or fragment thereof comprises an amino acid sequence which is at least 95% identical to the amino acid sequence of SEQ ID NO: 565, and wherein the amino acid sequence comprises a deletion of about 5 to about 20 amino acids from the C-terminal end of the amino acid sequence;

(b) contacting the recombinant host cell with a fermentation medium under conditions whereby isobutanol is produced; and

(c) optionally, recovering the isobutanol.

2. The method of claim 1 , wherein the amino acid sequence further comprises one or more amino acid substitutions selected from P378A, P378G, P378V, P378I, P378L, G383S, G383A, G383V, G383L, G383I, I387V, I387M, I387L, I387G, I387A, L388I, L388V, L388A, and L388M.

3. The method of claim 1 , wherein the polypeptide or fragment further comprises a polycysteine or polyhistidine tag.

4. The method of claim 1 , wherein the polypeptide or fragment further comprises the amino acid sequence of SEQ ID NO: 589.

5. The method of claim 2 , wherein the amino acid comprises the amino acid sequence of SEQ ID NO: 573.

6. The method of claim 1 , wherein the polypeptide or fragment further comprises a polypeptide sequence selected from SEQ ID NO: 723, SEQ ID NO: 724, SEQ ID NO: 725, SEQ ID NO: 726, SEQ ID NO: 727, SEQ ID NO: 728, SEQ ID NO: 729, SEQ ID NO: 730, SEQ ID NO: 731, SEQ ID NO: 732, SEQ ID NO: 733, SEQ ID NO: 734, SEQ ID NO: 735, SEQ ID NO: 736, SEQ ID NO: 737, SEQ ID NO: 738, SEQ ID NO: 739, SEQ ID NO: 740, SEQ ID NO: 741, SEQ ID NO: 742, SEQ ID NO: 743, SEQ ID NO: 744, SEQ ID NO: 745, SEQ ID NO: 746, SEQ ID NO: 747, and SEQ ID NO: 748.

7. The method of claim 1 , wherein the amino acid sequence comprises a deletion of about 5 to about 15 amino acids from the C-terminal end of the amino acid sequence.

8. The method of claim 1 , wherein the amino acid sequence comprises a deletion of 9 C-terminal amino acids.

9. The method of claim 1 , wherein the recombinant host cell comprises an isobutanol biosynthetic pathway.

10. The method of claim 9 , wherein the recombinant host cell is genetically modified to disrupt a gene encoding pyruvate decarboxylase (PDC).

11. The method of claim 9 , wherein the recombinant host cell is genetically modified to disrupt a gene encoding glycerol-3-phosphate dehydrogenase (GPD2).

12. The method of claim 1 , wherein the recombinant host cell is a yeast cell.

13. The method of claim 12 , wherein the yeast cell comprises a disruption in one or more endogenous genes affecting iron-sulfur cluster biosynthesis selected from FRA2, GRX3, GRX4, and CCC1.

14. The method of claim 1 , wherein the isobutanol is recovered by distillation, liquid-liquid extraction, adsorption, decantation, pervaporation, or combinations thereof.

15. The method of claim 1 , wherein the isobutanol is recovered by contacting the fermentation medium with a water immiscible extractant to form a two-phase mixture comprising an aqueous phase and an organic phase.

16. The method of claim 15 , wherein the extractant is selected from the group consisting of C 12 to C 22 fatty alcohols, C 12 to C 22 fatty acids, esters of C 12 to C 22 fatty acids, C 12 to C 22 fatty aldehydes, and mixtures thereof.

17. The method of claim 1 , wherein the isobutanol is recovered by contacting the isobutanol with an organic acid and a catalyst capable of esterifying the isobutanol with the organic acid.

18. The method of claim 1 , wherein solids are removed from the fermentation medium.

19. The method of claim 18 , wherein the solids are removed from the fermentation medium by centrifugation, filtration, decantation, or combinations thereof.

20. The method of claim 18 , wherein the solids are removed before the isobutanol is recovered.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2021
From: BUTAMAX ADVANCED BIOFUELS LLC
To: GEVO, INC.
Reel/Frame 057677/0477 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2021
From: ROTHMAN, STEVEN CARY; YE, RICK W.; MAGGIO-HALL, LORI ANN; PAUL, BRIAN JAMES
To: BUTAMAX ADVANCED BIOFUELS LLC
Reel/Frame 057305/0855 →
Continuity (7)
Continuation 14142398 · Dec 27, 2013
Provisional Application 61747158 · Dec 28, 2012
Provisional Application 61747161 · Dec 28, 2012
Provisional Application 61747178 · Dec 28, 2012
Provisional Application 61885924 · Oct 2, 2013
Provisional Application 61885939 · Oct 2, 2013
Related Publication 20170218405A1 · Aug 3, 2017